Figure 2
![Figure 2](http://media.springernature.com/full/springer-static/image/art%3A10.1186%2Fs12916-014-0185-3/MediaObjects/12916_2014_Article_185_Fig2_HTML.jpg)
Effects of PDE5i over placebo on cardiac geometry parameters. A) LVMi main analysis; B) LVMi subgroup analysis in patients with LVH; C) EDVi main analysis. Diamond indicates the overall summary estimate for the analysis (width of the diamond represents the 95% CI); boxes, the weight of individual studies in the pooled analysis. EDVi: end-diastolic volume index; LVH: left ventricular hypertrophy; LVMi: left ventricular mass index; PDE5i: phosphodiesterase type 5 inhibitors.